AstraZeneca acquires vaccine developer Icosavax for $1.1 billion
AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an ‘innovative’ treatment for respiratory viruses.
Cambridge, England-based pharmaceutical...
Tue, 12/12/2023 - 08:37